Layering in the Offering; Key MICVO Updates Ahead in 2H:26

Research evidence excerpt

Layering in the Offering; Key MICVO Updates Ahead in 2H:26

Company Specific Disclosures

1. WS makes a market in the securities of Pyxis Oncology, Inc..

Price Charts

Pyxis Oncology, Inc. Rating History as of 06-29-2026

powered by: BlueMatrix

OP:$6.00

05/05/2026

Oct 23 Jan 24 Apr 24 Jul 24 Oct 24 Jan 25 Apr 25 Jul 25 Oct 25 Jan 26 Apr 26

Closing Price Price Target

Outperform (OP); Neutral (N); Underperform (UP); Not Rated (NR)

Wedbush disclosure price charts are updated within the first fifteen days of each new calendar quarter per FINRA regulations. Price

charts for companies initiated upon in the current quarter, and rating and target price changes occurring in the current quarter, will not

be displayed until the following quarter. Additional information on recommended securities is available on request.

Disclosure information regarding historical ratings and price targets is available: Research Disclosures

Applicable disclosure information is also available upon request by contacting the Research Department at (212) 833-1375, by email to

leslie.lippai@wedbush.com. You may also submit a written request to the following: Wedbush Securities, Attn: Research Department,

142 W 57th Street, New York, NY 10019.

OTHER DISCLOSURES

The information herein is based on sources that we consider reliable, but its accuracy is not guaranteed. The information contained

herein is not a representation by this corporation, nor is any recommendation made herein based on any privileged information. This

information is not intended to be nor should it be relied upon as a complete record or analysis: neither is it an offer nor a solicitation

of an offer to sell or buy any security mentioned herein. This firm, Wedbush Securities, its officers, employees, and members of their